Mesothelioma is cancer that starts in the thin layer of tissue lining the chest, abdomen, and heart. The survival rate for mesothelioma patients is around 50% – 60%. This blog post will cover how to improve your odds of surviving this deadly cancer.
In this article, we’ll examine all the different ways you can survive mesothelioma as well as those who have already been diagnosed with it. We’ll also take a look at the research being done on new treatments and clinical trials happening all over the world. So, if you’re interested in learning more about what’s going on with mesothelioma today then read on!
Survival Rate of Mesothelioma
Survival rates can help you understand the chances of living a certain amount of time after being diagnosed with cancer. They’re not always accurate, but they might give an idea about how many people are still alive and well at least 5 years later in their condition.
Cancer is a scary word, and it can be hard to understand how these statistics apply in your case. However, knowing the survival rates will help you think about what kind of treatment options might best suit you as well as give some peace of mind that there could potentially be hope for recovery!
Keep reading if want more information on understanding cancer stats – like whether they are accurate or not dependant upon who was diagnosed with which type? Who knows exactly what someone else’s outcome would look like after receiving certain types of medicines/surgery etc.? These estimates may seem confusing at first but talking things over with the doctor should clear up any confusions.
What is a 5-year relative survival rate?
There are many different factors that can affect the survival rate for people with malignant pleural mesothelioma (MPM). For example, stage and type may make a difference in how long one lives after being diagnosed.
The 5-year relative survival rates show what portion of those who have this cancer compared to an overall population will live at least five more years too!
Where do these numbers come from?
The American Cancer Society relies on information from the SEER* database, maintained by the National Institutes of Health (NIH), to provide survival statistics for different types of cancer.
Read now: Real Benefits of Aloe Vera Juice
The SEER database tracks 5-year relative survival rates for MPM in the United States, based on how far the cancer has spread. The SEER database, however, does not group cancers by AJCC TNM stages (stage 1, stage 2, stage 3, etc.). Instead, it groups cancers into localized, regional, and distant stages:
- Localized: The cancer is limited to the pleura.
- Regional: The cancer has spread to nearby structures or to nearby lymph nodes.
- Distant: The cancer has spread to distant parts of the body such as the liver, bones or pleura on the other side of the body.
5-year relative survival rates for malignant pleural mesothelioma
|SEER Stage||5-Year Relative Survival Rate|
|All SEER stages combined||10%|
Understanding the numbers
- The numbers below apply only to the stage of cancer when it is first diagnosed. They do not take into account later stages if you get your disease back after treatment, or if it grows and spreads throughout your body.
- Cancer is a deadly disease that takes many forms. However, it’s important to note how your age and general health will affect the prognosis for you cancer diagnosis as there are other factors involved in figuring out what kind of mesotheloma tumor one has along with its stage at time when treating them too which all play into this outcome.
- People are now being diagnosed with MPM, but this may not reflect the full extent of their condition. Treatments improve over time and those numbers come from people who were treated at least five years ago.